title: [Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
authors.affiliation: Service d'Hépato-Gastroentérologie, Hôpital Saint-Antoine, Paris, France.
authors.forename: Tony
authors.initials: T
authors.lastname: Andreani
authors.forename: Olivier
authors.initials: O
authors.lastname: Chazouillères
authors.forename: Yvon
authors.initials: Y
authors.lastname: Calmus
authors.forename: Raoul
authors.initials: R
authors.lastname: Poupon
mesh_terms: D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000821:virology; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D004279:DNA, Viral; D019259:Lamivudine; D007372:Interferons
vernacular_title: Hépatite virale B: dangers et précautions d'emploi de la lamivudine.